Highlights
Building blocks for new medicines
The MWC uses New Zealand’s outstanding medicinal chemistry expertise to discover new medicines. A particular kind of chemistr...
read the full story
One cancer gene – but several different proteins
Cancer arises due to changes in DNA in a single cell. Many changes are needed over time to a cell’s DNA to make it cancerous...
read the full story
Turning the tables on cancer
Tumours often contain areas with less oxygen than is found in normal tissues. These areas are less vulnerable to many forms o...
read the full story
Mid-term review sets future direction
A comprehensive independent assessment found the Centre to be performing at a high level, producing distinct and positive ben...
read the full story
Smarter drug design
An advanced experimental technique linked to high powered computation is becoming an increasingly important tool for MWC rese...
read the full story
MWC welcomes landmark results for lung cancer drug
A novel lung cancer drug with strong development links to the MWC has shown impressive results in a large-scale international...
read the full story
Newly funded research highlights MWC collaborations
A five-year research programme aims to develop nontoxic vaccine technologies to complement existing cancer immunotherapies.
read the full story
The tumour-promoting activities of a famous protein
Developing new cancer therapies and a more reliable test for prostate cancer are just some of the potential outcomes of Mauri...
read the full story
MWC leads cancer immune therapy conversation
The Maurice Wilkins Centre continues to be part of an international drive to develop and improve immune therapy for cancer. I...
read the full story